drug
etonogestrel CR
Marketedupdated 3mo agoby $DARE Dare Bioscience, Inc.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for contraception and 7 investigational indications.
all catalysts(19)
approval · 19
Jul 17, 2006
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Jan 18, 2007
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Feb 19, 2009
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
May 13, 2011
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Feb 1, 2012
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Jun 12, 2013
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Sep 27, 2013
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Jul 3, 2014
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Aug 19, 2015
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Sep 3, 2015
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Mar 14, 2016
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
May 19, 2017
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Apr 22, 2019
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Sep 24, 2020
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Sep 24, 2020
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Sep 29, 2023
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Sep 29, 2023
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Sep 29, 2023
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Jan 16, 2026
approval
$OGN13.74+0.07%
IMPLANON (ETONOGESTREL) — FDA approval
etonogestrel CR
→
Trials studying etonogestrel CR
- phase2An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060)
- phase2A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
- phase3A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
- EP1Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel
- phase4Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
- phase2A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)
- phase2A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)
- phase3Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 28, 2026
7 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (5)
- Jul 28, 2030formulationUS 97575523.9y
- Jul 28, 2030formulationUS 97575523.9y
- Sep 28, 2027formulationUS 87220371.1y
- May 31, 2027formulationUS 10821277283d
- Aug 28, 2026formulationUS 88887457d
FDA exclusivities (1)
- Jan 16, 2029D-199New Indication (3y)2.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that